Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 160
-2
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can a Dietary Intervention Reduce Mercury Toxicity Among Native Communities in Peru?

    A state of emergency has been declared in Madre de Dios, Peru due to high levels of mercury (Hg) exposure...

    Next Generation Non-Seeing Eye Prosthesis

    This project aims to push the current state of the art in ocular prothestics by integrating a small system...

    S-glutathionylation reactions in mitochondrial function and disease

    This project was an invited review that is currently under minor revision at Frontiers Cellular and Developmental...

    Backer Badge Funded